Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
DNA polymerase eta
is recently found as a responsible gene product of xeroderma pigmentosum variant. Differently from other eukaryotic DNA polymerases, such as alpha, beta or gamma, eta polymerase is categorized in Y family. Specific inhibitors for DNA polymerases are useful tools to study the exact role of enzyme in the living cells, however, the inhibitor for
DNA polymerase eta
has not been developed. We examined the inhibitory effects of several sugar-modified nucleotide analogs on
DNA polymerase eta
. The arabinonucleotides (araCTP), dideoxynucleotides (ddTTP) and 3'-modified nucleotides (3'-dCTP and 3'-azidothymidine tri-phosphate) did not show any inhibitory effect on
DNA polymerase eta
. On the other hand, the oxetanocin derivatives those have the oxetane ring as a sugar moiety,
OXT
-GTP and
OXT
-ATP, strongly inhibited this polymerase. These results suggest that
DNA polymerase eta
has a unique recognition mode against the sugar moiety of nucleotide compared with other eukaryotic nucleotide polymerases.
...
PMID:Inhibition of DNA polymerase eta by oxetanocin derivatives. 1715 Sep 21